AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 4043476
Drug: Combined UVB-UVA
RxNorm normalized name: UVA URSI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined UVB-UVA treatment
Trial: 24154932
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg daily and low-fat diet
Trial: 18626299
Drug: ACE therapy
RxNorm normalized name: Salicylic Acid 0.5 g in 100 mL TOPICAL LIQUID [KOCOSTAR FACE THERAPY ACNE TREATMENT CREAM TO PATCH]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE therapy in addition to treatment as usual
Trial: 18626299
Drug: Supportive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive therapy in addition to treatment as usual
Trial: 17472487
Drug: Elixir composed
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elixir composed with air-dried C. papaya seeds and honey (CPH)
Trial: 14679383
Drug: 1-month isoflavone
RxNorm normalized name: moth bean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-month isoflavone supplementation (86 mg/day red clover-derived isoflavones)
Trial: 10783653
Drug: Intravenous PGI2
RxNorm normalized name: PGI2
DrugBank: Epoprostenol (DB01240)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous PGI2
Trial: 8439095
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid treatment for children with serum FA levels lower than 3 ng/ml
Trial: 8439095
Drug: Anticonvulsant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticonvulsant therapy
Trial: 3531452
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous infusion of gentamicin
Trial: 3531452
Drug: Multiple-dose therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-dose therapy of gentamicin
Trial: 30884079
Drug: CNI-free immunosuppression
RxNorm normalized name: acid red 337 free acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CNI-free immunosuppression with everolimus (EVR), mycophenolic acid and steroids
Trial: 30884079
Drug: Reduced-exposure CNI
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced-exposure CNI with EVR and steroids
Trial: 25336575
Drug: Topical brinzolamide
RxNorm normalized name: Brinzolamide
DrugBank: Brinzolamide (DB01194)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topical brinzolamide (Azopt)
Trial: 23605805
Drug: Sublingual 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual 10 mg Promptol™
Trial: 23605805
Drug: Oral Inderal(®)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Inderal(®)
Trial: 23605805
Drug: Sublingual 40
RxNorm normalized name: Sublingual Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual 40 mg Promptol™
Trial: 16290817
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy combined with vestibular rehabilitation (VR) program including psychoeducation, vestibular exercises, relaxation, and cognitive interventions.
Trial: 12628840
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of CMF treatment
Trial: 10692092
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (HRT) with sequential transdermal 17beta‐oestradiol for 14 weeks and then medroxyprogesterone (MPA) for 14 days
Trial: 8406404
Drug: Sublingual morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual morphine sulfate (10 mg)
Trial: 8406404
Drug: Oral morphine
RxNorm normalized name: morphine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral morphine sulfate (10 mg)
Trial: 8406404
Drug: Intramuscular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular morphine sulfate (10 mg)
Trial: 3088973
Drug: D‐alpha‐tocopherol (268
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D‐alpha‐tocopherol (268 mg)
Trial: 3088973
Drug: DL‐alpha‐tocopherol (364
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DL‐alpha‐tocopherol (364 mg)
Trial: 22442962
Drug: Antihypoxant reamberin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypoxant reamberin included in intensive treatment
Trial: 11568553
Drug: Dexamethasone 10
RxNorm normalized name: dexamethasone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 10 mg intravenously
Trial: 7933233
Drug: Hormonal treatment
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal treatment (orchiectomy or estrogens)
Trial: 7933233
Drug: Deferred treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferred treatment and radical prostatectomy
Trial: 31647577
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg DFN-15
Trial: 29683391
Drug: Grape Seed
RxNorm normalized name: grape seed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grape Seed Extract (GSE) 300 mg
Trial: 26979136
Drug: half dose
RxNorm normalized name: propranolol hydrochloride Extended Release Oral Capsule [Half-Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: half dose AV7909 on Days 0/14/28
Trial: 26979136
Drug: BioThrax vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BioThrax vaccine on Days 0/14/28
Trial: 25494177
Drug: Subcutaneous fat
RxNorm normalized name: Sus scrofa subcutaneous fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous fat suture closure
Trial: 22209361
Drug: Lu AA21004
RxNorm normalized name: Lu-DOTA-TATE
DrugBank: Lutetium Lu 177 dotatate (DB13985)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lu AA21004 2.5 mg
Trial: 12137819
Drug: Urethral dilation
RxNorm normalized name: CATH,URETHRAL DILATION 7FR #G17844
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urethral dilation with Benique dilatators (maximal 21F) under intraurethral anesthesia, starting 10 days after initial DVIU, protocol: weekly for the first month, once after 3 and 6 months, then annually.
Trial: 1944438
Drug: Acyclovir (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir (20 mg/kg, orally, four times daily for five days)
Trial: 6686118
Drug: beta-blockade (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: beta-blockade (50 mg oral metoprolol or 40 mg oral propranolol, each twice per day)
Trial: 23160696
Drug: 7.5 mg/ml
RxNorm normalized name: pectin 7.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg/ml ropivacaine (group A, 42 patients)
Trial: 23160696
Drug: 5 mg/ml
RxNorm normalized name: urea 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/ml levobupivacaine (group B, 44 patients)
Trial: 17469891
Drug: Education and
RxNorm normalized name: zinc pyrithione Medicated Shampoo [Free and Clear]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education and acceptance and commitment therapy (ACT)
Trial: 15660859
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron supplementation 4 mg/kg per day
Trial: 15660859
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no oral iron supplementation)
Trial: 3094411
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg cromolyn
Trial: 31526014
Drug: Low-dose CT
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CT (0.8 mSv)
Trial: 31526014
Drug: Standard-dose CT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose CT (4.2 mSv)
Trial: 18088241
Drug: Lamivudine (previous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine (previous treatment)
Trial: 8113478
Drug: Reminiscence Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reminiscence Therapy (RT)
Trial: 30993928
Drug: Endovascular intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Endovascular intervention treatment
Trial: 21196761
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (usual allergy medication)
Trial: 18070004
Drug: Melatonin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (5 mg) and bright-light therapy (1 hour of morning light exposure at > or = 2,500 lux)
Trial: 16527014
Drug: Oxymetazoline nasal
RxNorm normalized name: oxymetazoline nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxymetazoline nasal spray (0.05% concentration, one spray in each nostril, three times a day for 5 days)
Trial: 12866606
Drug: CI‐1023 (Ad(GV)VEGF121.10),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CI‐1023 (Ad(GV)VEGF121.10), a replication‐deficient adenovirus encoding human vascular endothelial growth factor isoform 121, administered via intramuscular injection (4 x 10(8) to 4 x 10(10) particle units)
Trial: 9340057
Drug: Chemotherapy (Carboplatine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (Carboplatine, Etoposide, Vincristine, 6 courses, 3-week basis)
Trial: 9340057
Drug: Chemoradiotherapy (same
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoradiotherapy (same chemotherapy regimen + primary site irradiation, total dose 40Gy)
Trial: 8349471
Drug: Piroxicam FDDF
RxNorm normalized name: Piroxicam
DrugBank: Piroxicam (DB00554)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Piroxicam FDDF (40 mg in a single sublingual dose)
Trial: 2882966
Drug: 5-aminosalicylic acid
RxNorm normalized name: 5-aminosalicylic acid
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-aminosalicylic acid (1000 mg, Pentasa)
Trial: 26179482
Drug: Tofogliflozin 5
RxNorm normalized name: sotagliflozin
DrugBank: Sotagliflozin (DB12713)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Tofogliflozin 5 mg
Trial: 26179482
Drug: Tofogliflozin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofogliflozin 2.5 mg
Trial: 21441078
Drug: AZLI 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZLI 75 mg administered 3-times daily for 28 days
Trial: 1905361
Drug: Minoxidil (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minoxidil (1 ml of a 2% solution)
Trial: 1905361
Drug: Nitroglycerin (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (2.5 gm of a 10% ointment)
Trial: 31187674
Drug: Luo Han
RxNorm normalized name: ALCOHOL 70 mL in 100 mL TOPICAL GEL [eluo Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Luo Han Guo decoction (30 mL administered starting 6 hours after surgery)
Trial: 25559811
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with capecitabine and cisplatin (XP)
Trial: 25559811
Drug: Concurrent chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiotherapy followed by adjuvant chemotherapy (XPRT)
Trial: 23567482
Drug: Preventive acetaminophen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive acetaminophen (15 mg/kg IV) plus 100 mL IV normal saline
Trial: 23567482
Drug: Preemptive acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preemptive acetaminophen (15 mg/kg IV) plus 100 mL IV normal saline
Trial: 23567482
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (100 mL IV normal saline as placebo)
Trial: 23567482
Drug: Preemptive acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preemptive acetaminophen (15 mg/kg IV)
Trial: 23567482
Drug: Preventive acetaminophen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive acetaminophen (15 mg/kg IV)
Trial: 22207070
Drug: rESWT in
RxNorm normalized name: Rest Simply
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: rESWT in spastic muscle + rESWT in antagonist muscle
Trial: 19955891
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine 3 microg/kg
Trial: 19955891
Drug: Placebo (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (oral pantoprazole 40 mg)
Trial: 11245349
Drug: Aqueous oral
RxNorm normalized name: Pen-Aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous oral vitamin E supplementation for 6 weeks
Trial: 9575674
Drug: Intralesional injection
RxNorm normalized name: DEXAMETHASONE SODIUM PHOSPHATE 4 mg in 1 mL INTRALESIONAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional injection of local anesthetic
Trial: 28253887
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (1-2 sessions of physiotherapy per week, hippotherapy, circuit training, and occupational therapy as necessary for 5 weeks)
Trial: 24758776
Drug: Intraperitoneal lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal lidocaine 50 mg/h (10 ml) once every hour
Trial: 24758776
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of lidocaine 50 mg/h (10 ml) IV
Trial: 24758776
Drug: Placebo saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo saline 10 ml/h both intravenously and intermittently intraperitoneal
Trial: 22717420
Drug: T80/H25 SPC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T80/H25 SPC (telmisartan/hydrochlorothiazide 80/25 mg)
Trial: 22717420
Drug: T80 (telmisartan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T80 (telmisartan 40 mg)
Trial: 20151774
Drug: Exenatide 5
RxNorm normalized name: EXENATIDE 5MCG/DOSE 1.2ML 60D PEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide 5 microg twice a day (titrated to 10 microg twice a day)
Trial: 20151774
Drug: Glibenclamide 2.5
RxNorm normalized name: glibenclamide 2.5 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide 2.5 mg three times a day (titrated to 5 mg three times a day)
Trial: 16230141
Drug: Intrarectal 100‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrarectal 100‐mg diclofenac suppository 1 hour before biopsy
Trial: 16230141
Drug: Glycerin suppository
RxNorm normalized name: Leader Pediatric Glycerin Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycerin suppository as placebo intrarectally 1 hour before biopsy
Trial: 12399191
Drug: HBsAg/AS04 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HBsAg/AS04 vaccine
Trial: 12399191
Drug: Established hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Established hepatitis B vaccine
Trial: 29641834
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of rACC theta marker with clinical and demographic variables
Trial: 24880442
Drug: Clobetasol propionate-neomycin-nystatin
RxNorm normalized name: Clobetasol Propionate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clobetasol propionate-neomycin-nystatin cream (CP-NN)
Trial: 17918748
Drug: Immunomodulation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunomodulation treatment
Trial: 2057620
Drug: Intramuscular premedication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular premedication with 0.2 mg/kg of midazolam and 0.015 mg/kg of atropine
Trial: 2057620
Drug: Intranasal premedication
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal premedication with 0.2 mg/kg of midazolam and 0.015 mg/kg of atropine
Trial: 2057620
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Intramuscular and Intranasal)
Trial: 24613032
Drug: Vabicaserin 200
RxNorm normalized name: Vabicaserin
DrugBank: Vabicaserin (DB12071)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vabicaserin 200 mg/day
Trial: 24613032
Drug: Vabicaserin 400
RxNorm normalized name: Vabicaserin
DrugBank: Vabicaserin (DB12071)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vabicaserin 400 mg/day
Trial: 20519076
Drug: Depsides salts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depsides salts from salvia miltiorrhiza (DSM) 0.2 g intravenously daily for 2 weeks
Trial: 17173661
Drug: Pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pegylated interferon alfa-2b (1.5 microg/kg/week) with ribavirin (800-1000 mg daily) for 48 weeks for genotype 1 and 4, 24 weeks for other genotypes
Trial: 2706173
Drug: Injection at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection at L2/3 with 3 ml of plain 0.5% bupivacaine
Trial: 2706173
Drug: Injection at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection at L4/5 with 3 ml of plain 0.5% bupivacaine
Trial: 351355
Drug: Dexchlorpheniramine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexchlorpheniramine (4 mg/70 kg)
Trial: 31925917
Drug: Long-pulsed Nd:YAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-pulsed Nd:YAG 1064-nm laser treatment
Trial: 31925917
Drug: Topical amorolfine
RxNorm normalized name: amorolfine Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical amorolfine nail lacquer alone
Trial: 31925917
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (laser + amorolfine)
Trial: 28873425
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IRS and OUT
Trial: 28873425
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IRS and LLIN
Trial: 28873425
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IRS and KOTAB
Trial: 25502833
Drug: Intravitreal ranibizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal ranibizumab (IVI) 0.5 mg with isovolemic hemodilution (IH)
Trial: 21815991
Drug: Smooth neck
RxNorm normalized name: Derma-Smoothe FS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smooth neck implant
Trial: 21815991
Drug: Pre-implant augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-implant augmentation procedure
Trial: 21261621
Drug: DFDBA +
RxNorm normalized name: DFBA
DrugBank: Difluprednate (DB06781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DFDBA + omega‐3 polyunsaturated fatty acids + low‐dose aspirin
Trial: 11106141
Drug: Gotu Kola
RxNorm normalized name: GOTU KOLA
DrugBank: Centella asiatica (DB14256)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gotu Kola (12-g orally administered dose)
Trial: 30409131
Drug: Full dose
RxNorm normalized name: BayRHo-D Full Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full dose dexmedetomidine (1.0 μg/kg loading followed by 0.5 μg/kg/min infusion)
Trial: 30409131
Drug: Half dose
RxNorm normalized name: propranolol hydrochloride Extended Release Oral Capsule [Half-Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half dose dexmedetomidine (0.5 μg/kg loading followed by 0.25 μg/kg/min infusion)
Trial: 20818904
Drug: Neoadjuvant platinum‐based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant platinum‐based chemotherapy followed by interval debulking surgery
Trial: 20818904
Drug: Primary debulking
RxNorm normalized name: Sodium primary phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary debulking surgery followed by platinum‐based chemotherapy
Trial: 19000553
Drug: Fesoterodine 4
RxNorm normalized name: fesoterodine 4 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fesoterodine 4 mg, 8 mg, or 12 mg sustained-release tablets
Trial: 19000553
Drug: Fesoterodine 8
RxNorm normalized name: fesoterodine 8 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fesoterodine 8 mg in fed state
Trial: 19000553
Drug: Fesoterodine at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fesoterodine at all doses
Trial: 1856145
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of amikacin (15 mg/kg) given iv over 30 min
Trial: 1856145
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of tobramycin (4.5 mg/kg) given iv over 30 min
Trial: 1856145
Drug: 24‐h continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24‐h continuous infusion of amikacin
Trial: 1856145
Drug: 24‐h continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24‐h continuous infusion of tobramycin
Trial: 1856145
Drug: Two injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two injections of amikacin (7.5 mg/kg)